Mark leads the commercial team at RIS Rx, bringing revenue and growth leadership across pharmacy and healthcare technology. Prior to RIS Rx, he held senior growth and sales roles at RedSail Technologies, leading commercial initiatives spanning strategic gross-to-net (GTN) optimization, pharmacy distribution, 340B dynamics, and patient affordability operations. He holds a BS in Business Administration (Finance) from Capella University.
Learn why the world's top pharmaceutical companies trust RIS Rx to protect their patients and improve GTN.
RIS Rx is pioneering real-time GTN Revenue Protection for the world's leading pharmaceutical manufacturers, ensuring that every dollar allocated for affordability reaches the right patients at the right time.